Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study

Autor:	Jyotsna M. Bhatavdekar, Karelia Nh, N Ghosh, Sunil Trivedi, Vora Hh, NG Shah, Balar Db, Devendra D. Patel
Rok vydání:	1994
Předmět:	Oncology CA15-3 endocrine system Cancer Research medicine.medical_specialty Time Factors Mammary gland Radioimmunoassay CA 15-3 Breast Neoplasms Breast cancer Carcinoembryonic antigen Epidermal growth factor Predictive Value of Tests Reference Values Internal medicine medicine Biomarkers Tumor Humans Insulin-Like Growth Factor I Neoplasm Staging Retrospective Studies biology Epidermal Growth Factor business.industry Mucin-1 Cancer Retrospective cohort study medicine.disease Prognosis Carcinoembryonic Antigen Prolactin Survival Rate Endocrinology medicine.anatomical_structure biology.protein Immunoradiometric Assay business hormones hormone substitutes and hormone antagonists Follow-Up Studies
Zdroj:	Breast cancer research and treatment. 30(3)
ISSN:	0167-6806
Popis:	A retrospective study was performed on 69 breast cancer patients (stage II, N = 18; advanced disease, N = 51) in order to assess the prognostic value of circulating prolactin (PRL), CEA, CA 15-3, insulin-like growth factor-1 (IGF-1), and epidermal growth factor (EGF) by RIA/IRMA. These markers were compared with short-term prognosis (two years). Significant difference was observed only for PRL (20.0 ng/ml vs.20.0 ng/ml), which provide an independent predictor of short-term prognosis in advanced breast cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14cc1aba22e4e5119e57d10df573f95 https://pubmed.ncbi.nlm.nih.gov/7981447 Zobrazit plný text záznamu Full text from SpringerLink